Dr. Lerner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11100 Euclid Ave
Cleveland, OH 44106Phone+1 216-844-3192Fax+1 216-201-6424
Summary
- Dr. Alan Lerner is a geriatrician in Beachwood, OH and is affiliated with multiple hospitals in the area, including UH Cleveland Medical Center and UH Ahuja Medical Center. He received his medical degree from Weill Cornell Medicine and has been in practice 30 years. He is experienced in general neurology, alzheimer's disease, and behavioral neurology / neuropsychiatry.
Education & Training
- Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Geriatric Medicine (Internal Medicine), 1991 - 1993
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Neurology, 1988 - 1991
- Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalInternship, Internal Medicine, 1987 - 1988
- Weill Cornell MedicineClass of 1987
Certifications & Licensure
- OH State Medical License 1989 - 2026
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Cataract Removal and Alzheimer's Disease Start of enrollment: 2009 Jun 01
- Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease Start of enrollment: 2012 Apr 01
- The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF) Start of enrollment: 2014 Jan 08
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsGenetic variants in the SHISA6 gene are associated with delayed cognitive impairment in two family datasets.Jairo Ramos, Laura J Caywood, Michael B Prough, Jason E Clouse, Sharlene D Herington
Alzheimer's & Dementia. 2023-02-01 - Minding the Future: Approaching Aging with a Plan.Alan J Lerner
Journal of Alzheimer's Disease. 2023-01-01 - 12 citationsCYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer's disease.Alan J Lerner, Steven E Arnold, Erin Maxfield, Aaron Koenig, Maria E Toth
Alzheimer's Research & Therapy. 2022-12-29
Press Mentions
- Can a Daily Multivitamin Slow Memory Decline in Seniors?September 19th, 2024
- Clinic, CWRU Among Ohio Sites Participating in Study to Slow Brain Changes That Lead to Alzheimer’sMarch 28th, 2023
- University Hospitals Enrolling Those with Early-Stage Alzheimer’s Disease in Study of New DrugDecember 29th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: